Due to the fact that coronavirus disease 2019 (COVID-19) is still prevalent, and current
reports show that some parts of the world have seen increase in incidence, it is relevant that …

During the current SARS-CoV-2 (COVID-19) pandemic, some reports were presented based
on those nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids may exacerbate …

Given the current SARS-CoV-2 (COVID-19) pandemic, the availability of reliable information
for clinicians and patients is paramount. There have been a number of reports stating that …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom …

The wide and rapid spread of the COVID-19 pandemic has placed an unanticipated burden
on the global healthcare sector. This necessitated a swift response from the international …

It has been reported that corticosteroid therapy was effective in the management of severe
acute respiratory syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) …

Introduction We conducted a comprehensive literature review to synthesize evidence for the
relationship between corticosteroid use and mortality in patients with COVID-19. Methods …

Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …

The underlying cause of many complications associated with severe COVID-19 is attributed
to the inflammatory cytokine storm that leads to acute respiratory distress syndrome (ARDS) …

Background COVID-19 is a type of pneumonia caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection that was identified in December 2019 …